非酒精性脂肪性肝病诊疗指南(2006年2月修订)

被引：73

作者：

机构：

[1] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组

来源：

现代消化及介入诊疗 | 2007年 / 04期

关键词：

非酒精性脂肪性肝病诊疗指南; 纤维化; 炎症; 弥漫性; 病理; 单纯性脂肪肝; NAFLD; 肝细胞脂肪变; 肝硬化; 汇管区; 门管区; 酒精性肝病;

D O I：

暂无

中图分类号：

R575.5 [肝代谢障碍];

学科分类号：

1002 ; 100201 ;

摘要：

非酒精性脂肪性肝病(NAFLD)是指除外酒精和其他明确的损肝因素所致的,以弥漫性肝细胞大泡性脂肪变为主要特征的临床病理综合征,包括单纯性脂肪肝以及由其演变的脂肪性肝炎(NASH)和肝硬化,胰岛素抵抗和遗传易感性与其发病关系密切。随着肥胖和糖尿病的高发,NAFLD现已成

引用

页码：266 / 268

页数：3

共 10 条

[1] 多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价 [J].

胡国平 ;

刘凯 ;

赵连三 .

肝脏, 2005, (01) :5-7

[2] Histopathology of pediatric nonalcoholic fatty liver disease [J].

Schwinnner, JB ;

Behling, C ;

Newbury, R ;

Deutsch, R ;

Nievergelt, C ;

Schork, NJ ;

Lavine, JE .

HEPATOLOGY, 2005, 42 (03) :641-649

[3] The metabolic syndrome [J].

Eckel, RH ;

Grundy, SM ;

Zimmet, PZ .

LANCET, 2005, 365 (9468) :1415-1428

[4] Hepatotoxicity of drugs used for treatment of obesity and its comorbidities [J].

Ghali, P ;

Lindor, KD .

SEMINARS IN LIVER DISEASE, 2004, 24 (04) :389-397

[5]

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference[J] . Brent A. Neuschwander‐Tetri,Stephen H. Caldwell.Hepatology . 2003 (5)

[6] Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis [J].

Harrison, SA ;

Torgerson, S ;

Hayashi, P ;

Ward, J ;

Schenker, S .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (11) :2485-2490

[7]

American Gastroenterological Association medical position statement: Nonalcoholic fatty liver disease[J] . Gastroenterology . 2002 (5)

[8]

Management of Nonalcoholic Steatohepatitis: An Analytic Review[J] . Sanjay Agrawal,Herbert L. Bonkovsky.Journal of Clinical Gastroenterology . 2002 (3)

[9]

AGA technical review on nonalcoholic fatty liver disease[J] . Arun J. Sanyal.Gastroenterology . 2002 (5)

[10] Use of ursodeoxycholic acid in patients with liver disease. [J].

Angulo P. .

Current Gastroenterology Reports, 2002, 4 (1) :37-44

← 1 →